Masaru Aoyagi

Dr. Masaru Aoyagi

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
KTKaoru Tamura
Kaoru Tamura
MAMasaru Aoyagi
Masaru Aoyagi
Hiroaki WakimotoHiroaki Wakimoto
Hiroaki Wakimoto
MTMasashi Tamaki
Masashi Tamaki
KYKohei Yamamoto
Kohei Yamamoto
KOKikuo Ohno
Kikuo Ohno

1 June 2010 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
TKToshinori Kubota
Toshinori Kubota
NONobuo Ohta
Nobuo Ohta
SFShigeru Fukase
Shigeru Fukase
YKYoshihisa Kon
Yoshihisa Kon
MAMasaru Aoyagi
Masaru Aoyagi

1 April 2011 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
TCTanmay Chattopadhyay
Tanmay Chattopadhyay
MKMasaki Kogiso
Masaki Kogiso
MAMasaru Aoyagi
Masaru Aoyagi
HYHiroharu Yui
Hiroharu Yui
MAMasumi Asakawa
Masumi Asakawa
TSToshimi Shimizu
Toshimi Shimizu
Organic nanotubes self-assembled from lipid compounds facilitate the synthesis of a new nano-catalyst with nickel ions. The nickel ions were fixed on the surface of the organic nanotubes through coordination. The nanotubes catalyzed oxidation of a wide range of organic compounds with hydrogen peroxide without organic solvent, and are reusable in at least five cycles without loss of activity.

11 November 2013 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
NONobuo Ohta
Nobuo Ohta
SFShigeru Fukase
Shigeru Fukase
YSYusuke Suzuki
Yusuke Suzuki
KKKazuya Kurakami
Kazuya Kurakami
MAMasaru Aoyagi
Masaru Aoyagi
SKSeiji Kakehata
Seiji Kakehata
Our results confirmed that OK-432 therapy is simple, easy, safe, and effective and can be used as a substitute for surgery in the treatment of ranula extending to the parapharyngeal space. The aim of this study was to evaluate the outcome and complications of the OK-432 treatment of patients with ranula extending to the parapharyngeal space. This was a case series with planned data collection at Yamagata University and Fukase clinic. We tried this therapy in six patients with ranula extending to the parapharyngeal space, between January 2001 and February 2012. We injected OK-432 solution into the lesion with an 18 or 27 gauge needle depending on the patient's condition (location and size of ranula and complications). This treatment was performed on an outpatient basis without hospitalization. Disappearance or marked reduction of the lesion were observed in all patients who had this therapy, and local scarring and deformity of the injection sites did not occur in any patients. As side effects, local pain at the injection site and fever (37-39°C) were observed in 40% of the patients who had this therapy, but such problems resolved within a few days.

1 May 2016 in Carbon
Verified
Journal Article
Closed access
MAMasaru Aoyagi
Masaru Aoyagi
MYMasako Yudasaka
Masako Yudasaka
HMHiroyuki Minamikawa
Hiroyuki Minamikawa
MAMasumi Asakawa
Masumi Asakawa
MMMitsutoshi Masuda
Mitsutoshi Masuda
SISumio Iijima
Sumio Iijima

7 September 2007 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Open access
PDF file
MTMasashi Tamaki
Masashi Tamaki
MAMasaru Aoyagi
Masaru Aoyagi
TKToshihiko Kuroiwa
Toshihiko Kuroiwa
MYMasaaki Yamamoto
Masaaki Yamamoto
SKSeiji Kishimoto
Seiji Kishimoto
KOKikuo Ohno
Kikuo Ohno
The management of clival chordoma remains problematic. We present the case of a 48-year-old woman with clival chordoma who underwent multiple surgeries and radiation therapy, including gamma knife stereotactic radiosurgery (GK-SRS), during a 10-year clinical course. The tumor was initially removed by gross total resection via the trans-sphenoidal approach, followed by external linac radiation therapy. The tumor recurred at the clivus 5 years after the initial operation. After repeated trans-sphenoidal removal of recurrent tumors, she twice underwent GK-SRS for a tumor remnant adjacent to the brainstem. Although this part of the tumor was controlled by GK-SRS, there was further tumor extension toward the sphenoid and maxillary sinuses. Ultimately, lower cranial nerve dysfunction developed due to tumor extension into the lower part of the clivus and the patient died of respiratory failure. Autopsy revealed the tumor to extend from the lower clivus to the bilateral middle fossae. The lower part of the tumor extended to the nasal cavity and to the posterior wall of the pharynx, resulting in compression of the upper pharyngeal region. The tumor around the jugular foramen compressed the lower cranial nerves bilaterally. Tumor cells did not, however, invade the intradural space microscopically. Although chordoma is not biologically malignant, this tumor can show massive extension with destruction of bony structures and extracranial invasion of connective tissues. Therefore, the optimal treatment strategy is to remove the tumor mass as extensively as possible, including normal bony structures and connective tissues surrounding the tumor, using skull base surgical techniques.